OSCR Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines

03
Prix $30.94
P/E (TTM) 21.3
BPA (TTM) $1.45
Revenu (TTM) $15.32B
ROE (TTM) 34.3%
Dette/Capitaux propres (MRQ) 0.2
Fourchette 52 semaines $11–$34

OSCR Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue

04
fourchette
barres

La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.

À propos de Oscar Health, Inc. Class A Common Stock Présentation de l'entreprise depuis Wikipedia

05 · wikidata

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

History

2012–2015

According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Kushner and his brother, Jared, owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.

2016

Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".

In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."

2017

On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.

On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.

A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Kushner's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.

While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.

2020–present

In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."

As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."

Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.

Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.

Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO.

In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.

Marketing and brand

Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".

In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.

In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.

Finances

Funding

Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.

During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.

During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.

In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.

During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.

In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.

Revenue

In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.

Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."

By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.

In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.

In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.

In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.

In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.

Headquarters and offices

Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.

Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗

Wikidata ↗

secteurFinancials industrieInsurance employés2 305 paysUS

Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA

06
Revenu$11.70B
2019-12-31 → 2025-12-31
BPA$-1.69
2019-12-31 → 2025-12-31
Flux de trésorerie libre$1.06B
2021-12-31 → 2025-12-31
Marge nette3.6%
2021-12-31 → 2025-12-31
Valorisation et Ratios 07–12

Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?

Métrique Tendance sur 5 ans OSCR moyenne 5 ans Médiane des pairs Verdict
P/E (TTM) 21.3moyenne 5 ans ≈23.0 ≈23.0 15.4 Surévalué

La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.

valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane

Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats

14
Surprise Moyenne 24.3%
Prochain rapport Nov 04, 2026
PériodeRapportEPS ActualBPA est.Surprise
30 juin 2026 Aoû 6, 2026 $1.10 $0.39 179.5%
31 mars 2026 $2.07 $1.21 71.5%
31 décembre 2025 $-1.24 $-0.91 -37.0%
30 septembre 2025 $-0.53 $-0.57 6.6%
30 juin 2025 $-0.89 $-0.47 -88.5%
31 mars 2025 $0.92 $0.81 13.8%

Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie

15
Compte de résultat 13
Métrique Tendance 202520242023202220212020
Revenue $11.70B$9.18B$5.86B$3.96B$1.84B$463M
SG&A Expense $2.05B$1.76B$1.43B$1.26B$265M$167M
Operating Income $-396M$57M$-236M$-590M$-544M$-402M
Interest Expense ··$25M$23M$5M$4M
Other Non-op $-23M$-105.0K$-7M$2M$-1M·
Pretax Income $-437M$33M$-267M$-610M$-571M$-406M
Income Tax $6M$7M$3M$-523.0K$846.0K$1M
Net Income $-443M$25M$-271M$-606M$-573M$-407M
EPS (Basic) $-1.69$0.11$-1.22$-2.85$-3.20$-14.16
EPS (Diluted) $-1.69$0.10$-1.22$-2.85$-3.20$-14.16
Shares (Basic) 262,388,000240,386,000221,655,000212,475,000178,967,05629,263,424
Shares (Diluted) 262,388,000265,853,000221,655,000212,475,000178,967,05629,263,424
EBITDA $-367M$89M$-205M·$-530M·
Bilan 23
Métrique Tendance 202520242023202220212020
Cash & Equivalents $2.77B$1.53B$1.87B$1.56B$1.10B$826M
Short-term Investments ·$624M$690M···
Receivables $363M·····
Other Current Assets $24M$21M$7M$6M$4M·
Current Assets $4.61B$2.85B$3.06B$4.12B$2.31B$1.87B
PP&E (Net) $88M$67M$62M$60M$47M$36M
PP&E (Gross) $230M$181M$150M$117M$89M$63M
Accum. Depreciation $142M$114M$88M$57M$42M$27M
Other Non-current Assets $120M$82M$83M$95M$97M$13M
Total Assets $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
Accounts Payable $507M$432M$273M$298M$235M$138M
Current Liabilities $4.86B$3.46B$2.43B$3.26B$1.85B$1.67B
Capital Leases $52M$61M$67M$72M$77M·
Other Non-current Liabilities $52M$61M$68M$72M$77M$0
Total Liabilities $5.34B$3.82B$2.80B$3.63B$1.93B$1.82B
Total Debt $430M$300M$299M·$0·
Common Stock ·····$2.0K
Paid-in Capital $4.26B$3.87B$3.68B$3.51B$3.39B$133M
Retained Earnings $-3.29B$-2.85B$-2.88B$-2.61B$-2.00B$-1.43B
Treasury Stock $3M$3M$3M$3M$3M$3M
AOCI $18M$-2M$1M$-10M$-4M$879.0K
Stockholders' Equity $978M$1.01B$804M$890M$1.39B$-1.30B
Liabilities + Equity $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
Flux de trésorerie 16
Métrique Tendance 202520242023202220212020
D&A $29M$32M$31M$15M$15M$11M
Stock-based Comp $88M$110M$160M$112M$86M$36M
Deferred Tax $2M$-2M$58.0K$-165.0K$-101.0K$-67.0K
Other Non-cash $1.42B$813M$-192M·$290M·
Operating Cash Flow $1.09B$978M$-272M$380M$-182M$223M
CapEx $36M$28M$26M$29M$26M$14M
Investing Cash Flow $-241M$-1.39B$577M$-227M$-775M$-345M
Debt Issued $410M$0$0$305M$0$147M
Net Debt Issued $410M$0$0···
Stock Repurchased ····$0$0
Net Stock Activity ····$0·
Financing Cash Flow $399M$68M$6M$301M$1.24B$612M
Net Change in Cash $1.25B$-341M$311M$455M$282M$490M
Taxes Paid $18M$674.0K$2M$2M$697.0K$2M
Free Cash Flow $1.06B$950M$-298M·$-208M·
Levered FCF ··$-323M·$-212M·
Rentabilité 7
Métrique Tendance 202520242023202220212020
Operating Margin -3.4%0.62%-4.0%·-29.6%·
Net Margin -3.8%0.28%-4.6%·-31.1%·
Pretax Margin -3.7%0.36%-4.6%·-31.0%·
EBITDA Margin -3.1%0.97%-3.5%·-28.8%·
ROA -7.9%0.60%-6.7%·-20.5%·
ROE -44.5%2.8%-32.0%·-36.7%·
ROIC -28.5%3.4%-21.6%·-39.3%·
Liquidité et Solvabilité 5
Métrique Tendance 202520242023202220212020
Current Ratio 0.90.81.3·1.2·
Quick Ratio 0.60.60.8·0.6·
Debt / Equity 0.40.30.4·0.0·
LT Debt / Equity 0.40.30.4·0.0·
Interest Coverage ··-9.6·-115.4·
Efficacité 1
Métrique Tendance 202520242023202220212020
Asset Turnover 2.12.21.4·0.7·
Par action 3
Métrique Tendance 202520242023202220212020
Revenue / Share $44.60$34.52$26.45·$10.27·
Cash Flow / Share $4.17$3.68$-1.23·$-1.02·
EPS (TTM) $-1.69$0.10$-1.22$-2.85$-3.20·
Taux de croissance 3
Métrique Tendance 202520242023202220212020
Revenue YoY 27.5%56.5%47.9%115.6%297.3%·
Revenue CAGR 3Y 43.5%70.9%133.1%···
Revenue CAGR 5Y 90.8%·····
Valorisation (TTM) 4
Métrique Tendance 202520242023202220212020
Revenue TTM $11.70B$9.18B$5.86B$3.96B$1.84B·
Net Income TTM $-443M$25M$-271M$-606M$-573M·
P/E -8.5134.4-7.5-0.9-2.5·
Earnings Yield -11.8%0.74%-13.3%-115.9%-40.8%·

Période la plus récente à gauche · valeurs nulles affichées comme ·

États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années

16
Métrique 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenu $11.70B $9.18B $5.86B $3.96B $1.84B
Marge d'exploitation % -3.4% 0.62% -4.0% · -29.6%
Résultat net $-443M $25M $-271M $-606M $-573M
BPA dilué $-1.69 $0.10 $-1.22 $-2.85 $-3.20

Détenteurs institutionnels (13F) 459 déclarants · $6.2B total · Au 30 septembre 2026

17

Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.

Détenteurs 459
Valeur détenue $6.2B
Nouvelles positions 125
Positions clôturées 46
Activité institutionnelle — Q2 2026 vs trimestre précédent
Nouvelles positions Positions clôturées Augmenté Diminué Variation nette des actions
125 (+51 vs T. préc.) 46 (-18 vs T. préc.) 147 (+22 vs T. préc.) 115 (+3 vs T. préc.) +22.8M

Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.

Institution Valeur Actions % de 13F suivies Type
BlackRock, Inc. $587 153 449 20 587 428 9,50% Actions
D. E. Shaw & Co., Inc. $360 595 957 12 643 617 5,84% Actions
VANGUARD PORTFOLIO MANAGEMENT LLC $314 559 172 11 029 424 5,09% Actions
VANGUARD CAPITAL MANAGEMENT LLC $301 725 543 10 579 437 4,88% Actions
VANGUARD GROUP INC $297 476 962 20 701 250 4,82% Actions
AMERICAN CENTURY COMPANIES INC $258 255 502 9 055 242 4,18% Actions
JANE STREET GROUP, LLC $181 530 912 6 365 039 2,94% Actions
Thrive Capital Management, LLC $180 919 957 6 343 617 2,93% Actions
GEODE CAPITAL MANAGEMENT, LLC $165 994 311 5 819 186 2,69% Actions
STATE STREET CORP $165 454 531 5 801 351 2,68% Actions
SUSQUEHANNA INTERNATIONAL GROUP, LLP $162 917 648 5 712 400 2,64% Option d'achat
FMR LLC $142 557 861 4 998 523 2,31% Actions
CITADEL ADVISORS LLC $120 626 823 4 229 552 1,95% Actions
TWO SIGMA INVESTMENTS, LP $115 097 850 4 035 689 1,86% Actions
DIMENSIONAL FUND ADVISORS LP $101 885 043 3 571 731 1,65% Actions
BIT Capital GmbH $97 480 134 3 417 957 1,58% Actions
RENAISSANCE TECHNOLOGIES LLC $93 673 940 3 284 500 1,52% Actions
JACOBS LEVY EQUITY MANAGEMENT, INC $86 282 012 3 025 316 1,40% Actions
GLYNN CAPITAL MANAGEMENT LLC $73 462 615 2 575 828 1,19% Actions
CITADEL ADVISORS LLC $72 469 320 2 541 000 1,17% Option d'achat
GOLDMAN SACHS GROUP INC $65 298 165 2 289 557 1,06% Actions
NORTHERN TRUST CORP $63 063 680 2 211 209 1,02% Actions
WOLVERINE ASSET MANAGEMENT LLC $61 825 656 2 167 800 1,00% Option de vente
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60 458 493 2 119 863 0,98% Actions
MORGAN STANLEY $60 299 272 2 114 280 0,98% Actions
SUSQUEHANNA INTERNATIONAL GROUP, LLP $55 351 616 1 940 800 0,90% Option de vente
JANE STREET GROUP, LLC $53 968 396 1 892 300 0,87% Option d'achat
Nuveen, LLC $50 501 648 1 770 745 0,82% Actions
BlackBarn Capital Partners LP $49 910 000 1 750 000 0,81% Option de vente
BNP PARIBAS FINANCIAL MARKETS $48 660 710 1 706 196 0,79% Actions
VANGUARD FIDUCIARY TRUST CO $45 996 029 1 612 764 0,74% Actions
CITADEL ADVISORS LLC $44 459 828 1 558 900 0,72% Option de vente
STATE OF MICHIGAN RETIREMENT SYSTEM $41 354 000 1 450 000 0,67% Actions
BANK OF AMERICA CORP /DE/ $37 594 294 1 318 173 0,61% Actions
Assenagon Asset Management S.A. $35 592 732 1 247 992 0,58% Actions
TWO SIGMA ADVISERS, LP $35 534 136 2 472 800 0,58% Actions
UBS Group AG $34 596 357 1 213 056 0,56% Actions
JANE STREET GROUP, LLC $33 796 200 1 185 000 0,55% Option de vente
GROUP ONE TRADING LLC $32 744 154 1 148 112 0,53% Actions
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $31 200 652 1 093 992 0,51% Actions
Qube Research & Technologies Ltd $30 913 940 1 083 939 0,50% Actions
TUDOR INVESTMENT CORP ET AL $29 055 948 1 018 792 0,47% Actions
GILDER GAGNON HOWE & CO LLC $28 576 515 1 001 982 0,46% Actions
JPMORGAN CHASE & CO $26 387 407 885 558 0,43% Actions
FEDERATED HERMES, INC. $26 096 200 915 014 0,42% Actions
WELLS FARGO & COMPANY/MN $23 408 907 820 789 0,38% Actions
Walleye Capital LLC $23 243 058 814 974 0,38% Actions
Point72 Asset Management, L.P. $22 809 212 799 762 0,37% Actions
Walleye Trading LLC $22 744 700 797 500 0,37% Option d'achat
Bank of New York Mellon Corp $22 032 138 772 515 0,36% Actions

Afficher les 459 détenteurs institutionnels →

Activistes et détenteurs de 5%+ 2 participations

18

Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.

Déclarant Déposé Participation Statut Objectif Dépôt
Claremount TW, L.P., Claremount V Associates, L.P., Claremount VI Associates, L.P., Claremount VII Associates, L.P., Joshua Kushner, Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., Thrive Capital Partners V, L.P., Thrive Capital Partners VI Growth, L.P., Thrive Capital Partners VII Growth, L.P., Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII GP, LLC, Thrive Partners VII Growth GP, LLC 18 septembre 2026 12,10% Amendement · SEC
Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 dépôts 13 novembre 2024 · Dépôt initial · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Initiés de la société 23 initiés · 12 dirigeants · 12 administrateurs

19
Dirigeant Rôle Dernière activité Actions détenues Achats 12m Ventes 12m Net 12m
Mark T Bertolini Chief Executive Officer 30 juin 2026 S 7 751 570 1 8 $-58 759 399
Richard Scott Blackley Chief Financial Officer 3 septembre 2026 S 1 046 108 0 9 $-7 941 907
Janet Liang President, Oscar Insurance 3 septembre 2026 S 248 697 0 5 $-821 072
Steven Wolin Chief Operating Officer 1 décembre 2024 M 102 598 0 0 $0
Meghan V. Joyce Chief Operating Officer 1 mars 2022 M 43 070 0 0 $0
Joshua Kushner Co-Founder and Vice Chairman 18 septembre 2026 J 0 0 0 $0
Victoria Baltrus Chief Accounting Officer 3 septembre 2026 S 213 631 0 5 $-194 480
Adam Mcananey Chief Legal Officer 3 septembre 2026 S 209 004 0 5 $-783 513
Alessandrea C. Quane EVP, Chief Insurance Officer 5 décembre 2024 M 430 216 0 0 $0
Ranmali Bopitiya EVP & Chief Legal Officer 1 décembre 2024 M 241 488 0 0 $0
Dennis Weaver Chief Clinical Officer 1 décembre 2022 M 27 110 0 0 $0
Joel Klein Chief Policy & Strat. Officer 18 août 2021 M 17 0 0 $0
Vanessa Ames Wittman Administrateur 18 septembre 2026 S 112 121 0 1 $-806 000
Mario Schlosser Administrateur 3 septembre 2026 S 449 444 0 29 $-68 790 950
William Gassen Administrateur 9 juillet 2026 A 82 840 0 0 $0
David Plouffe Administrateur 9 juillet 2026 A 137 121 0 0 $0
Sid Sankaran Administrateur 9 juillet 2026 A 22 609 0 0 $0
Laura W Lang Administrateur 4 juin 2026 A 82 840 0 0 $0
Jeffery H Boyd Administrateur 9 avril 2026 A 705 673 0 0 $0
Elbert O. Robinson Jr. Administrateur 12 mai 2025 S 64 512 0 0 $0
Jr Charles E Phillips Administrateur 14 octobre 2022 A 85 787 0 0 $0
Teri List-Stoll Administrateur 5 mars 2021 A 50 000 0 0 $0
Ari Fischel · 5 mars 2021 A 0 0 0 $0

Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché

Détention d'ETF Détenu par 46 ETFs

20

Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.

Fonds Poids Unités Au Source
ABLS · Abacus FCF ETF Trust 5,83% 867 NS 31 juillet 2026 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1,98% 235 668 SH 1 octobre 2026 Quotidien
RNIN · EA Series Trust 1,20% 70 047 NS 31 juillet 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0,74% 307 696 NS 31 juillet 2026 N-PORT
JSML · Janus Detroit Street Trust 0,60% 69 666 NS 31 juillet 2026 N-PORT
IWO · iShares Trust 0,52% 2 269 828 SH 11 septembre 2026 Quotidien
JSMD · Janus Detroit Street Trust 0,51% 171 181 NS 31 juillet 2026 N-PORT
DWAS · Invesco Exchange-Traded Fund Trust … 0,45% 58 846 SH 1 octobre 2026 Quotidien
VTWG · VANGUARD SCOTTSDALE FUNDS 0,40% 258 034 SH 19 août 2026 Quotidien
FYX · First Trust Exchange-Traded AlphaDE… 0,35% 152 933 NS 31 juillet 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,31% 8 798 NS 31 juillet 2026 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,27% 61 099 NS 31 juillet 2026 N-PORT
FYEE · Fidelity Greenwood Street Trust 0,27% 19 102 NS 31 juillet 2026 N-PORT
IWM · iShares Trust 0,26% 6 175 602 SH 11 septembre 2026 Quotidien
FBUF · Fidelity Greenwood Street Trust 0,25% 1 889 NS 31 juillet 2026 N-PORT
ISCG · iShares Trust 0,24% 71 367 SH 11 septembre 2026 Quotidien
RSSL · Global X Funds 0,24% 115 406 NS 31 juillet 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,21% 1 387 125 SH 19 août 2026 Quotidien
FHEQ · Fidelity Greenwood Street Trust 0,21% 61 010 NS 31 juillet 2026 N-PORT
VBK · VANGUARD INDEX FUNDS 0,19% 3 171 535 SH 19 août 2026 Quotidien
PRFZ · Invesco Exchange-Traded Fund Trust 0,17% 148 826 SH 1 octobre 2026 Quotidien
DFAS · Dimensional ETF Trust 0,16% 805 292 NS 31 juillet 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,15% 27 872 NS 31 juillet 2026 N-PORT
ESML · iShares Trust 0,11% 96 895 SH 11 septembre 2026 Quotidien
FNCL · FIDELITY COVINGTON TRUST 0,08% 61 975 NS 31 juillet 2026 N-PORT
VB · VANGUARD INDEX FUNDS 0,08% 5 488 922 SH 19 août 2026 Quotidien
VFH · VANGUARD WORLD FUND 0,08% 384 466 SH 19 août 2026 Quotidien
WSML · iShares Trust 0,07% 14 630 SH 11 septembre 2026 Quotidien
VXF · VANGUARD INDEX FUNDS 0,07% 2 534 194 SH 19 août 2026 Quotidien
IUS · Invesco Exchange-Traded Self-Indexe… 0,04% 12 473 SH 1 octobre 2026 Quotidien
DFSU · Dimensional ETF Trust 0,03% 20 892 NS 31 juillet 2026 N-PORT
DCOR · Dimensional ETF Trust 0,02% 21 472 NS 31 juillet 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 286 808 NS 31 juillet 2026 N-PORT
TILT · FlexShares Trust 0,02% 12 166 NS 31 juillet 2026 N-PORT
DFAU · Dimensional ETF Trust 0,01% 50 403 NS 31 juillet 2026 N-PORT
IWV · iShares Trust 0,01% 64 590 SH 11 septembre 2026 Quotidien
VTI · VANGUARD INDEX FUNDS 0,01% 7 601 113 SH 19 août 2026 Quotidien
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 194 738 SH 19 août 2026 Quotidien
VTHR · VANGUARD SCOTTSDALE FUNDS 0,01% 19 808 SH 19 août 2026 Quotidien
DFUS · Dimensional ETF Trust 0,01% 66 708 NS 31 juillet 2026 N-PORT
ESGV · VANGUARD WORLD FUND 0,01% 53 203 SH 19 août 2026 Quotidien
ITOT · iShares Trust 0,01% 287 602 SH 11 septembre 2026 Quotidien
DXUV · Dimensional ETF Trust 0,00% 472 NS 31 juillet 2026 N-PORT
IAK · iShares Trust · 117 671 SH 11 septembre 2026 Quotidien
ISCB · iShares Trust · 10 063 SH 11 septembre 2026 Quotidien
SMLF · iShares Trust · 286 871 SH 11 septembre 2026 Quotidien

OSCR Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse

21
notation · 19 analystes ACHAT
Objectif médian $33.50 +8,3%
2 10,5% Achat fort
7 36,8% Achat
9 47,4% Conserver
1 5,3% Vente
0 0,0% Vente forte

Objectif de cours à 12 mois

10 analystes · 2026-10-03

Objectif moyen $35.40 +14,4%

Maintenant Prix actuel $30.94
Bas$26.00 Moyenne$35.40 Haut$49.00

Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur

22

Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.

Ticker Capitalisation Boursière P/E Revenus Année/Année Marge Nette ROE Marge Brute
OSCR · -8.5 27.5% -3.8% -44.5% ·
AFL $57.20B 16.2 -9.3% 21.2% 12.9% ·
PRU · · · · · ·
PFG $19.18B 16.8 -3.1% 7.6% 10.3% ·
UNM · · · · · ·
GL $12.90B 9.9 3.7% 19.4% 20.4% ·
PRI $8.22B 11.3 6.6% 22.8% 31.9% ·
LNC $8.46B 7.6 -1.2% 6.5% 12.3% ·
CNO $4.01B 18.5 0.85% 5.1% 8.9% ·

Dernières actualités Actualités récentes mentionnant cette entreprise

23

Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets

26

Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.

Votre sélection est enregistrée et vous suit sur tous les tickers.

Source : Dépôt SEC 10-Q le Aoû 7, 2026